NT
Nexo Therapeutics, Inc.
SEC filingBiotechnology · Littleton, CO
Amount raised$60Msold at filing
Total offering$60M
Investors in the raise7count reported to the SEC
FiledMar 27, 2026first sale Nov 15, 2022
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Ali BehbahaniDirector
Andrew PhillipsExecutive Officer, Director
Carlo RizzutoDirector
Executive officers, directors and promoters as listed on the Form D.